These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23437911)

  • 21. Cholestatic syndrome with bile duct damage and loss in renal transplant recipients with HCV infection.
    Delladetsima JK; Makris F; Psichogiou M; Kostakis A; Hatzakis A; Boletis JN
    Liver; 2001 Apr; 21(2):81-8. PubMed ID: 11318976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report.
    Xie W; Wang Q; Gao Y; Pan CQ
    BMC Gastroenterol; 2018 Sep; 18(1):142. PubMed ID: 30268094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AIDS-related cholangiopathy. Critical analysis of a prospective series of 26 patients.
    Benhamou Y; Caumes E; Gerosa Y; Cadranel JF; Dohin E; Katlama C; Amouyal P; Canard JM; Azar N; Hoang C
    Dig Dis Sci; 1993 Jun; 38(6):1113-8. PubMed ID: 8389687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful Treatment with Steroids in a Patient with Vanishing Bile Duct Syndrome and Acute Tubular Necrosis.
    Mizuno F; Imai N; Yasuda K; Yokoyama S; Yamamoto K; Ito T; Ishizu Y; Honda T; Ishigami M; Kawashima H
    Intern Med; 2024 Jan; 63(1):57-61. PubMed ID: 37164665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An update on AIDS-related cholangiopathy.
    De Angelis C; Mangone M; Bianchi M; Saracco G; Repici A; Rizzetto M; Pellicano R
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):79-82. PubMed ID: 19212310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vanishing bile duct syndrome: a rare cause of jaundice in Hodgkin's lymphoma.
    Amer S; Muqeetadnan M; Rahman A; Nusrat S; Hassan S
    Turk J Gastroenterol; 2013; 24(5):444-6. PubMed ID: 24557970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vanishing Bile Duct Syndrome Associated With Non-Hodgkin's Lymphoma and Hepatitis E Virus Infection.
    Zafar M; Farooq M; Butler-Manuel W; Khattak MF; Rana UI; Muhammad T; Hawley I; Whitehead M; Toqeer M
    Cureus; 2022 Jan; 14(1):e21328. PubMed ID: 35070583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urosodeoxycholic Acid Therapy in a Child with Trimethoprim-Sulfamethoxazole-induced Vanishing Bile Duct Syndrome.
    Cho HJ; Jwa HJ; Kim KS; Gang DY; Kim JY
    Pediatr Gastroenterol Hepatol Nutr; 2013 Dec; 16(4):273-8. PubMed ID: 24511525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Spontaneous resolution of vanishing bile duct syndrome in Hodgkin's lymphoma].
    Han WS; Jung ES; Kim YH; Kim CH; Park SC; Lee JY; Chang YJ; Yeon JE; Byun KS; Lee CH
    Korean J Hepatol; 2005 Jun; 11(2):164-8. PubMed ID: 15980675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vanishing Bile Duct Syndrome in an Adult Patient: Case Report and Review of the Literature.
    Izzo P; Gallo G; Codacci Pisanelli M; D'Onghia G; Macci L; Gabriele R; Polistena A; Izzo L; Izzo S; Basso L
    J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Endoscopic cholangiography in biliary tract diseases in HIV+ patients].
    Currás A; Olmos M; Martinez A; Baez E; Coronado Quesada E; Magnanini F; Peralta C
    Acta Gastroenterol Latinoam; 1998; 28(3):237-41. PubMed ID: 9773151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-induced Liver Injury Considered Steroid-resistant and Histologically Diagnosed with Vanishing Bile Duct Syndrome.
    Shionoya K; Kobayashi M; Kako M; Masuda S; Makazu M; Koizumi K
    Intern Med; 2024 Jun; 63(12):1719-1723. PubMed ID: 37952956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytomegalovirus infection does not increase the risk of vanishing bile duct syndrome after liver transplantation.
    van den Berg AP; Klompmaker IJ; Hepkema BG; Gouw AS; Haagsma EB; Lems SP; The TH; Slooff MJ
    Transpl Int; 1996; 9 Suppl 1():S171-3. PubMed ID: 8959818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vanishing Bile Duct Syndrome in a Patient with Uterine Cancer and Paraneoplastic Systemic Sclerosis.
    Sedhom D; Herrmann A; D'Souza M; Fyfe B; Zaldana F; Schlesinger N; Rustgi V
    ACG Case Rep J; 2018; 5():e95. PubMed ID: 30643839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation.
    O'Grady JG; Alexander GJ; Sutherland S; Donaldson PT; Harvey F; Portmann B; Calne RY; Williams R
    Lancet; 1988 Aug; 2(8606):302-5. PubMed ID: 2899720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma.
    Hubscher SG; Lumley MA; Elias E
    Hepatology; 1993 Jan; 17(1):70-7. PubMed ID: 7678577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AIDS Cholangiopathy.
    Yusuf TE; Baron TH
    Curr Treat Options Gastroenterol; 2004 Apr; 7(2):111-117. PubMed ID: 15010025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology, determinants, and management of AIDS cholangiopathy: A review.
    Naseer M; Dailey FE; Juboori AA; Samiullah S; Tahan V
    World J Gastroenterol; 2018 Feb; 24(7):767-774. PubMed ID: 29467548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extrahepatic biliary stricture associated with cytomegalovirus in a liver transplant recipient.
    Kowdley KV; Fawaz KA; Kaplan MM
    Transpl Int; 1996; 9(2):161-3. PubMed ID: 8639259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vanishing bile duct syndrome-related jaundice as the first presentation of Hodgkin lymphoma.
    Mellat-Ardakani M; Salahshour F; Rafsanjani K; Avanaki FA; Azizi M
    Radiol Case Rep; 2023 Sep; 18(9):3291-3294. PubMed ID: 37483375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.